A Novel Synthetic Small Molecule YH-306 Suppresses Colorectal Tumour Growth and Metastasis Via FAK Pathway

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2014 Oct 30

PMID 25351103

Citations 8

Authors

Fujun Dai

Yihua Chen

Li Huang

Jinhua Wang

Tao Zhang

Jingjie Li

Weiguang Tong

Mingyao Liu

Zhengfang Yi

Affiliations

Soon will be listed here.

Abstract

Cell migration and invasion are key processes in the metastasis of cancer, and suppression of these steps is a promising strategy for cancer therapeutics. The aim of this study was to explore small molecules for treating colorectal cancer (CRC) and to investigate their anti-metastatic mechanisms. In this study, six CRC cell lines were used. We showed that YH-306 significantly inhibited the migration and invasion of CRC cells in a dose-dependent manner. In addition, YH-306 inhibited cell adhesion and protrusion formation of HCT116 and HT-29 CRC cells. Moreover, YH-306 potently suppressed uninhibited proliferation in all six CRC cell lines tested and induced cell apoptosis in four cell lines. Furthermore, YH-306 inhibited CRC colonization in vitro and suppressed CRC growth in a xenograft mouse model, as well as hepatic/pulmonary metastasis in vivo. YH-306 suppressed the activation of focal adhesion kinase (FAK), c-Src, paxillin, and phosphatidylinositol 3-kinases (PI3K), Rac1 and the expression of matrix metalloproteases (MMP) 2 and MMP9. Meanwhile, YH-306 also inhibited actin-related protein (Arp2/3) complex-mediated actin polymerization. Taken together, YH-306 is a candidate drug in preventing growth and metastasis of CRC by modulating FAK signalling pathway.

Citing Articles

The Role of SCARA5 as a Potential Biomarker in Squamous Cell Carcinoma of the Lung.

Flockerzi F, Hohneck J, Langer F, Trankenschuh W, Stahl P Int J Mol Sci. 2024; 25(13).

PMID: 39000462 PMC: 11242384. DOI: 10.3390/ijms25137355.

THSD7A Positivity Predicts Poor Survival and Is Linked to High FAK Expression and FGFR1-Wildtype in Female Patients with Squamous Cell Carcinoma of the Lung.

Flockerzi F, Hohneck J, Langer F, Bohle R, Stahl P Int J Mol Sci. 2023; 24(13).

PMID: 37445817 PMC: 10342182. DOI: 10.3390/ijms241310639.

SCARA5 Is Overexpressed in Prostate Cancer and Linked to Poor Prognosis.

Flockerzi F, Hohneck J, Saar M, Bohle R, Stahl P Diagnostics (Basel). 2023; 13(13).

PMID: 37443605 PMC: 10340403. DOI: 10.3390/diagnostics13132211.

THSD7A Positivity Is Associated with High Expression of FAK in Prostate Cancer.

Flockerzi F, Hohneck J, Saar M, Bohle R, Stahl P Diagnostics (Basel). 2023; 13(2).

PMID: 36673031 PMC: 9857569. DOI: 10.3390/diagnostics13020221.

Long Non-Coding RNA LINC01410 Promoted Tumor Progression the ErbB Signaling Pathway by Targeting STAT5 in Gallbladder Cancer.

Lu L, Zhang S, Song Z, Lu W, Wang Z, Zhou Y Front Oncol. 2021; 11:659123.

PMID: 34322379 PMC: 8312242. DOI: 10.3389/fonc.2021.659123.

References

DeMali K, Barlow C, Burridge K . Recruitment of the Arp2/3 complex to vinculin: coupling membrane protrusion to matrix adhesion. J Cell Biol. 2002; 159(5):881-91. PMC: 2173392. DOI: 10.1083/jcb.200206043. View

To C, Shilton B, Di Guglielmo G . Synthetic triterpenoids target the Arp2/3 complex and inhibit branched actin polymerization. J Biol Chem. 2010; 285(36):27944-57. PMC: 2934661. DOI: 10.1074/jbc.M110.103036. View

Thamilselvan V, Craig D, Basson M . FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway. FASEB J. 2007; 21(8):1730-41. DOI: 10.1096/fj.06-6545com. View

Yang J, Sun M, Zhang A, Lv C, De W, Wang Z . Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells. World J Surg Oncol. 2011; 9:117. PMC: 3198948. DOI: 10.1186/1477-7819-9-117. View

He T, Sparks A, Rago C, Hermeking H, Zawel L, DA COSTA L . Identification of c-MYC as a target of the APC pathway. Science. 1998; 281(5382):1509-12. DOI: 10.1126/science.281.5382.1509. View

Chatzizacharias N, Kouraklis G, Theocharis S . Clinical significance of FAK expression in human neoplasia. Histol Histopathol. 2008; 23(5):629-50. DOI: 10.14670/HH-23.629. View

Shih Y, Chien S, Chen P, Lee J, Wu S, Yin L . Alpha-mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via alphavbeta3 integrin/FAK/ERK and NF-kappaB signaling pathway in human lung adenocarcinoma A549 cells. Cell Biochem Biophys. 2010; 58(1):31-44. DOI: 10.1007/s12013-010-9091-2. View

Chen H, Appeddu P, Isoda H, Guan J . Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J Biol Chem. 1996; 271(42):26329-34. DOI: 10.1074/jbc.271.42.26329. View

Aman A, Piotrowski T . Cell migration during morphogenesis. Dev Biol. 2009; 341(1):20-33. DOI: 10.1016/j.ydbio.2009.11.014. View

10.

Lassmann S, Tang L, Capanu M, Brabletz T, Schopflin A, Zur Hausen A . Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy. Gastroenterology. 2007; 133(6):1831-9. DOI: 10.1053/j.gastro.2007.08.075. View

11.

Golas J, Lucas J, Etienne C, Golas J, Discafani C, Sridharan L . SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models. Cancer Res. 2005; 65(12):5358-64. DOI: 10.1158/0008-5472.CAN-04-2484. View

12.

Yeatman T . A renaissance for SRC. Nat Rev Cancer. 2004; 4(6):470-80. DOI: 10.1038/nrc1366. View

13.

Lai L, Liu J, Zhai D, Lin Q, He L, Dong Y . Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2. Br J Pharmacol. 2011; 165(4b):1084-96. PMC: 3346245. DOI: 10.1111/j.1476-5381.2011.01532.x. View

14.

Ten Klooster J, Evers E, Janssen L, Machesky L, Michiels F, Hordijk P . Interaction between Tiam1 and the Arp2/3 complex links activation of Rac to actin polymerization. Biochem J. 2006; 397(1):39-45. PMC: 1479755. DOI: 10.1042/BJ20051957. View

15.

Lin Y, Xiong X, Wharton S, Martin S, Coombs P, Vachieri S . Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc Natl Acad Sci U S A. 2012; 109(52):21474-9. PMC: 3535595. DOI: 10.1073/pnas.1218841110. View

16.

Chang F, Lemmon C, Park D, Romer L . FAK potentiates Rac1 activation and localization to matrix adhesion sites: a role for betaPIX. Mol Biol Cell. 2006; 18(1):253-64. PMC: 1751318. DOI: 10.1091/mbc.e06-03-0207. View

17.

Song Y, Dai F, Zhai D, Dong Y, Zhang J, Lu B . Usnic acid inhibits breast tumor angiogenesis and growth by suppressing VEGFR2-mediated AKT and ERK1/2 signaling pathways. Angiogenesis. 2012; 15(3):421-32. DOI: 10.1007/s10456-012-9270-4. View

18.

Kawauchi T . Cell adhesion and its endocytic regulation in cell migration during neural development and cancer metastasis. Int J Mol Sci. 2012; 13(4):4564-4590. PMC: 3344232. DOI: 10.3390/ijms13044564. View

19.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

20.

Otsubo T, Iwaya K, Mukai Y, Mizokami Y, Serizawa H, Matsuoka T . Involvement of Arp2/3 complex in the process of colorectal carcinogenesis. Mod Pathol. 2004; 17(4):461-7. DOI: 10.1038/modpathol.3800062. View